Dawid Schellingerhout Selected Research

Matrix Metalloproteinases (MMPs)

1/2013	Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out mice.
5/2011	Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dawid Schellingerhout Research Topics

Disease

11	Neoplasms (Cancer) 10/2023 - 09/2008
10	Stroke (Strokes) 11/2021 - 10/2005
9	Thrombosis (Thrombus) 10/2023 - 02/2005
8	Atherosclerosis 11/2021 - 09/2009
5	Infarction (Infarctions) 11/2021 - 04/2004
5	Hemorrhage 01/2021 - 10/2005
4	Ischemic Stroke 11/2021 - 12/2011
3	Inflammation (Inflammations) 11/2018 - 09/2009
2	Papillary Thyroid Cancer 09/2022 - 05/2013
2	Cerebral Infarction 11/2021 - 01/2021
2	Intracranial Thrombosis (Cerebral Thrombosis) 11/2021 - 01/2015
1	Carotid Artery Thrombosis 10/2023
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 09/2022
1	Embolic Stroke 11/2021
1	Glioma (Gliomas) 10/2019
1	Edema (Dropsy) 11/2018
1	Necrosis 11/2018
1	Hyperlipidemias (Hyperlipidemia) 12/2014
1	Atrial Fibrillation 12/2014
1	Diabetes Mellitus 12/2014
1	Hematoma 08/2014
1	Phototoxic Dermatitis (Phototoxicity) 06/2013
1	Atrophy 05/2013
1	Renal Artery Obstruction (Renal Artery Stenosis) 05/2013
1	Carotid Artery Diseases 01/2013
1	Primary Hyperparathyroidism 09/2012
1	Rupture 10/2011
1	Photosensitivity Disorders (Photodermatitis) 10/2011
1	Atherosclerotic Plaque (Atheroma) 05/2011
1	Weight Gain 05/2011
1	Carotid Stenosis (Carotid Artery Stenosis) 03/2010

Drug/Important Bio-Agent (IBA)

4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 05/2013
3	Pyruvic Acid (Pyruvate)IBA 10/2023 - 11/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 10/2011
3	Contrast MediaIBA 10/2019 - 02/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
2	CalciumIBA 01/2021 - 01/2017
2	LipidsIBA 08/2016 - 05/2011
2	GoldIBA 01/2016 - 05/2013
2	Therapeutic UsesIBA 01/2016 - 03/2010
2	CholesterolIBA 12/2014 - 12/2011
2	LuciferasesIBA 01/2013 - 12/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 05/2011
2	Cathepsin BIBA 10/2011 - 09/2009
2	Atorvastatin (Lipitor)FDA Link 10/2011 - 09/2009
2	Peptide Hydrolases (Proteases)FDA Link 03/2010 - 09/2009
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	Colloids (Colloid)IBA 09/2022
1	AnticoagulantsIBA 01/2021
1	N(4)-oleylcytosine arabinosideIBA 01/2021
1	Dabigatran FDA Link 01/2021
1	CarbonIBA 10/2019
1	3,6-di-O-acetyl-2-deoxy-D-glucopyranoseIBA 10/2019
1	FluorineIBA 05/2019
1	SolutionsIBA 01/2019
1	Amino Acids FDA Link 11/2018
1	Complement System Proteins (Complement)IBA 11/2018
1	Gadolinium DTPA (Magnevist)FDA Link 02/2017
1	IronIBA 01/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2016
1	HDL CholesterolIBA 08/2016
1	Apolipoproteins B (ApoB)IBA 08/2016
1	FibrinIBA 01/2016
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2016
1	CY5.5 cyanine dyeIBA 01/2016
1	Durapatite (Hydroxylapatite)IBA 01/2015
1	ferric oxide (iron oxide)IBA 01/2015
1	AgarIBA 01/2015
1	Evans Blue (Blue, Evans)FDA Link 08/2014
1	iopromide (Ultravist)FDA Link 08/2014
1	triphenyltetrazoliumIBA 08/2014
1	Tyrosine Kinase InhibitorsIBA 05/2013
1	Sorafenib (BAY 43-9006)FDA Link 05/2013
1	glycol-chitosanIBA 05/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	lipoprotein cholesterolIBA 12/2011
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2011
1	Photosensitizing Agents (Photosensitizers)IBA 10/2011
1	Clopidogrel (Plavix)FDA Link 10/2011
1	Cardiovascular AgentsIBA 10/2011
1	Blood Glucose (Blood Sugar)IBA 05/2011
1	LeptinIBA 05/2011
1	AdiponectinIBA 05/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2010

Therapy/Procedure

9	Therapeutics 01/2021 - 10/2005
4	Intravenous Injections 10/2019 - 05/2013
2	Thrombectomy 11/2021 - 01/2019
2	Radiotherapy 11/2018 - 09/2006
2	Thrombolytic Therapy 01/2015 - 05/2013
1	Transjugular Intrahepatic Portasystemic Shunt 01/2020
1	Aftercare (After-Treatment) 10/2019
1	Secondary Prevention 11/2018
1	Drug Therapy (Chemotherapy) 11/2018
1	Precision Medicine 01/2015
1	Intravenous Infusions 08/2014
1	Ligation 01/2013
1	Parathyroidectomy 09/2012
1	Lasers (Laser) 12/2011
1	Photochemotherapy (Photodynamic Therapy) 10/2011